首页>
外国专利>
AFRICAN TRYPANOSOMIASIS THERAPY WITH A NANOBODY-CONJUGATED HUMAN TRYPANOLYTIC FACTOR
AFRICAN TRYPANOSOMIASIS THERAPY WITH A NANOBODY-CONJUGATED HUMAN TRYPANOLYTIC FACTOR
展开▼
机译:纳米体结合人胰多囊性因子对非洲锥虫病的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the treatment of trypanosomiasis using a nanobody- conjugated trypanolytic factor. More specifically, it relates to a therapy with nanobody- conjugated human apo-L1, whereby said apo-L1 is preferably truncated at the C-terminal end to avoid neutralization by the trypanosomes.
展开▼